| The YVLDHLIVV peptide is derived from the BRLF1 protein of Epstein-Barr virus (EBV), an immediate-early lytic cycle protein. This epitope is presented by HLA-A*02:01 and recognized by CD8+ T cells. It is used in studies of EBV-specific immune responses, vaccine development, and understanding the role of T cells in controlling EBV infections. |
